Dark Spots & PIH Protocol: The Evidence-Based Removal Guide

Dark spots and PIH are not the same condition — and treating them the same way is why most people get mediocre results. Post-inflammatory hyperpigmentation (PIH) is triggered by inflammation, while solar lentigines (sun spots) are driven by cumulative UV exposure. Melasma is hormonally amplified UV pigmentation. Each requires a different primary intervention hierarchy. This is the SerumScientist.com evidence-based guide to removing all three.

1. PIH: The Inflammation-Melanogenesis Link

PIH forms when keratinocyte inflammation signals (PGE2, LTC4) stimulate adjacent melanocytes to overproduce melanin during the wound healing cascade. This excess melanin deposits in the epidermis (epidermal PIH — responds well to topicals) or leaks into the dermis as melanophages (dermal PIH — responds poorly to all topicals). Epidermal PIH in darker skin tones is the primary target for topical intervention. (Sugimoto K et al. PMID:15276452)

2. Alpha-Arbutin: The Most Widely Used OTC Tyrosinase Inhibitor

Alpha-arbutin is a glycosylated hydroquinone derivative that competitively inhibits tyrosinase at its active copper site without the mutagenicity concerns associated with hydroquinone. The alpha configuration provides superior stability and efficacy vs. beta-arbutin. At 2–4%, alpha-arbutin produces measurable melanin index reduction after 4 weeks of daily application. (Sugimoto K et al. PMID:15276452) L2

3. Kojic Acid: Copper Chelation at the Tyrosinase Active Site

Kojic acid inhibits tyrosinase via a different mechanism to arbutin — chelating the copper ions at the enzyme’s active site rather than competing for the substrate. This complementary mechanism makes kojic acid + alpha-arbutin a synergistic combination for resistant pigmentation. At 1–2%, kojic acid produces significant depigmentation in PIH and solar lentigines. (Maeda K et al. PMID:8558445) L2

4. Tranexamic Acid + Niacinamide: The Upstream Combination

Tranexamic acid addresses pigmentation upstream by interrupting the UV-melanogenesis signalling pathway (plasminogen activator inhibition), while niacinamide works downstream by inhibiting melanosome transfer from melanocytes to keratinocytes — preventing pigment from distributing within the epidermis even if melanin is produced. (Ebrahimi B et al. PMID:25371664) Together, they form a complete upstream + downstream anti-pigmentation system complementary to tyrosinase inhibitors.

The SS Dark Spots & PIH Protocol

AM: Gentle cleanser → Vitamin C 15% → Niacinamide 5–10% → Moisturiser → SPF 50+ (mandatory)

PM: Gentle cleanser → Tranexamic acid 5% OR Kojic Acid Serum → Alpha-arbutin 2% → Retinol 0.3–0.5% (3x/week) → Ceramide moisturiser

Weekly: Lactic acid 10% exfoliation (1–2x/week) to accelerate surface pigment desquamation

PIH prevention: Anti-inflammatory intervention during active breakouts — niacinamide and azelaic acid immediately post-inflammation reduce PIH formation

The SS Perspective

The secret to dark spot removal is not finding the one magic ingredient — it is running three to four complementary mechanisms simultaneously: tyrosinase inhibition, melanosome transfer block, UV protection, and cell turnover acceleration. Add SPF 50+ every morning as your primary intervention, layer in one tyrosinase inhibitor and niacinamide, and use a retinoid 3–5 nights per week for turnover. That combination — sustained over 6 months — will outperform any single brightening serum.

Robert Lee
The Serum Scientist — Founder, SerumScientist.com

© 2026 SerumScientist.com. All rights reserved. This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before beginning any new skincare regimen.